MRUS

Merus N.V. (MRUS)

About Merus N.V. (MRUS)

Merus NV is a clinical-stage immuno-oncology company, which engages in the discovery and development of bispecific antibody therapeutics. Its pipeline includes Biclonics for solid and hematological tumors. The company was founded by Ton Logtenberg and Hennie Hoogenboom on June 16, 2003 and is headquartered in Utrecht, the Netherlands.

Details

Daily high

$43.26

Daily low

$41.59

Price at open

$42.39

52 Week High

$61.61

52 Week Low

$27.11

Market cap

2.9B

Dividend yield

0.00%

Volume

937,303

Avg. volume

669,416

P/E ratio

-10.71

Merus N.V. News